Texas Cardiac Arrhythmia Institute First US Site for New PFA Trial
Austin – September 07, 2026 -- The Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center has become the first facility in the United States to enroll in a clinical trial evaluating a next-generation mapping and pulsed field ablation (PFA) system for patients with paroxysmal and persistent atrial fibrillation.
TCAI performs first procedure under global study leadership
Andrea Natale, M.D., executive medical director of TCAI and global principal investigator for the trial, conducted the first procedure using the new catheter system. The trial is designed to assess the safety and efficacy of the technology across both forms of atrial fibrillation, the most common cardiac arrhythmia, which affects millions of patients worldwide.